Galaxy Diagnostics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-03.
Galaxy Diagnostics, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 3, 2026. The filing reports $3.02M sold. Its industry group is Biotechnology. It names Nicole Bell (Executive Officer, Director), B. Clark (Executive Officer, Director), Richard West (Director) (SEC Form D, June 3, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Galaxy Diagnostics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Galaxy Diagnostics, Inc.
Free to see. No signup.
More on the people and the money behind Galaxy Diagnostics, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when Galaxy Diagnostics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Galaxy Diagnostics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Galaxy Diagnostics, Inc. →Get the full cited report on Galaxy Diagnostics, Inc.
What the filing shows about Galaxy Diagnostics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Galaxy Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Galaxy Diagnostics, Inc.'s address as 6 Davis Drive, Suite 832, Durham, NC 27713.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Galaxy Diagnostics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Galaxy Diagnostics, Inc. See pricing
Galaxy Diagnostics, Inc. is a registered filer with the SEC (CIK 1462444) and has filed since 2024-07-10. 3 filings are on record, the latest on 2026-06-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Galaxy Diagnostics, Inc.'s Form D of 2026-06-03 names Nicole Bell, B. Clark, Richard West and 3 more as its officers, directors or promoters.
Its new offerings report $7.99M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $3.02M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Other than the payment of salaries and other compensation and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
Nicole Bell is named as Executive Officer and Director on the Form D that Galaxy Diagnostics, Inc. filed with the SEC on 3 June 2026, one of 6 people that filing names.
B. Clark is named as Executive Officer and Director on the Form D that Galaxy Diagnostics, Inc. filed with the SEC on 3 June 2026, one of 6 people that filing names.
Richard West is named as Director on the Form D that Galaxy Diagnostics, Inc. filed with the SEC on 3 June 2026, one of 6 people that filing names.
Edward Breitschwerdt is named as Director on the Form D that Galaxy Diagnostics, Inc. filed with the SEC on 3 June 2026, one of 6 people that filing names.
Amanda Elam is named as Director on the Form D that Galaxy Diagnostics, Inc. filed with the SEC on 3 June 2026, one of 6 people that filing names.
Joel Kimbrough is named as Director on the Form D that Galaxy Diagnostics, Inc. filed with the SEC on 3 June 2026, one of 6 people that filing names.
6 people named on the filing — 2 holding an executive role and 4 as directors only.
Named as of the 2026-06-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Galaxy Diagnostics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Galaxy Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Galaxy Diagnostics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Galaxy Diagnostics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Galaxy Diagnostics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Galaxy Diagnostics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/galaxy-diagnostics-inc-form-d-26000001